Kymera Therapeutics annual asset turnover
2020
2021
2022
2023
2024
2025
Kymera Therapeutics Asset Turnover Growth & History (KYMR)
Kymera Therapeutics's asset turnover was 0.03 for fiscal 2025.
View full Kymera Therapeutics company overviewKymera Therapeutics annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.03 | −0.03 | −52.43% |
| 2024 | 2024-12-31 | 0.06 | −0.07 | −54.56% |
| 2023 | 2023-12-31 | 0.13 | 0.06 | +72.13% |
| 2022 | 2022-12-31 | 0.08 | −0.06 | −41.87% |
| 2021 | 2021-12-31 | 0.13 | 0.02 | +18.22% |
| 2020 | 2020-12-31 | 0.11 | — | — |
Kymera Therapeutics quarterly asset turnover
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.08 | 0.03 | +65.53% |
| Q1 2026 | 2026-03-31 | 0.04 | −0.03 | −39.64% |
| Q4 2025 | 2025-12-31 | 0.03 | −0.03 | −52.43% |
| Q3 2025 | 2025-09-30 | 0.04 | −0.07 | −62.90% |
| Q2 2025 | 2025-06-30 | 0.05 | −0.08 | −63.67% |
| Q1 2025 | 2025-03-31 | 0.07 | −0.04 | −38.48% |
| Q4 2024 | 2024-12-31 | 0.06 | −0.07 | −54.56% |
| Q3 2024 | 2024-09-30 | 0.11 | 0.03 | +40.24% |
| Q2 2024 | 2024-06-30 | 0.13 | 0.03 | +34.55% |
| Q1 2024 | 2024-03-31 | 0.11 | 0.03 | +35.12% |
| Q4 2023 | 2023-12-31 | 0.13 | 0.06 | +72.13% |
| Q3 2023 | 2023-09-30 | 0.08 | 0.01 | +9.63% |
| Q2 2023 | 2023-06-30 | 0.09 | −0.03 | −21.10% |
| Q1 2023 | 2023-03-31 | 0.08 | −0.04 | −36.08% |
| Q4 2022 | 2022-12-31 | 0.08 | −0.06 | −41.87% |
| Q3 2022 | 2022-09-30 | 0.07 | −0.05 | −41.35% |
| Q2 2022 | 2022-06-30 | 0.12 | −0.12 | −49.41% |
| Q1 2022 | 2022-03-31 | 0.12 | — | — |
| Q4 2021 | 2021-12-31 | 0.13 | — | — |
| Q3 2021 | 2021-09-30 | 0.12 | — | — |
| Q2 2021 | 2021-06-30 | 0.23 | — | — |
Kymera Therapeutics asset turnover trends
Over the last five fiscal years, Kymera Therapeutics's asset turnover decreased from 0.11 to 0.03, a change of −0.08. The latest reported quarter, Q2 2026, shows 0.08.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kymera Therapeutics source filings ↗Community posts
Kymera reports early human results for oral IRF5 drug
Kymera ($KYMR) reported results from its first human study of KT-579, an experimental oral medicine targeting the immune regulator IRF5. In healthy volunteers receiving repeated doses, median blood IRF5 reductions reached at least 90% acros ...
